Cargando…
Association of the FDA Amendment Act with trial registration, publication, and outcome reporting
BACKGROUND: Selective clinical trial publication and outcome reporting has the potential to bias the medical literature. The 2007 Food and Drug Administration (FDA) Amendment Act (FDAAA) mandated clinical trial registration and outcome reporting on ClinicalTrials.gov, a publicly accessible trial reg...
Autores principales: | Phillips, Adam T., Desai, Nihar R., Krumholz, Harlan M., Zou, Constance X., Miller, Jennifer E., Ross, Joseph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516301/ https://www.ncbi.nlm.nih.gov/pubmed/28720112 http://dx.doi.org/10.1186/s13063-017-2068-3 |
Ejemplares similares
-
Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
por: Zou, Constance X., et al.
Publicado: (2018) -
Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis
por: Ross, Joseph S., et al.
Publicado: (2009) -
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
por: Miller, Jennifer E, et al.
Publicado: (2015) -
Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016) -
Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018)